Journal article
Age-related macular degeneration
RH Guymer, TG Campbell
Lancet | Published : 2023
Abstract
Age-related macular degeneration is an increasingly important public health issue due to ageing populations and increased longevity. Age-related macular degeneration affects individuals older than 55 years and threatens high-acuity central vision required for important tasks such as reading, driving, and recognising faces. Advances in retinal imaging have identified biomarkers of progression to late age-related macular degeneration. New treatments for neovascular age-related macular degeneration offer potentially longer-lasting effects, and progress is being made towards a treatment for atrophic late age-related macular degeneration. An effective intervention to slow progression in the earli..
View full abstractGrants
Funding Acknowledgements
This study was supported by funding from the National Health and Medical Research Council (grant number 1194667; RHG) and the Hector Maclean Fellowship University of Melbourne (TGC) . Figure 5 was provided by Una Greferath from the University of Melbourne.